It is an IL-6 receptor (IL-6R) blocker that can effectively block the IL-6 signal transduction pathway and thus is likely to become an effective drug for patients with severe COVID-19 and to reduce the mortality [102]. This evidence concerns the gene IL6 and COVID-19.